Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Clinical trial NCT00116688 · COMPLETED

Trial details

NCT number: NCT00116688
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocytopenia Idiopathic Thrombocytopenic Purpura

Start date: 2004-08-01
Primary completion: 2010-01-01
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.